73 related articles for article (PubMed ID: 10452584)
21. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
22. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
23. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
24. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
25. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
26. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
[TBL] [Abstract][Full Text] [Related]
27. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
28. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
29. Intralesional verapamil for the treatment of Peyronie's disease: a review.
Levine LA; Estrada CR
Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
[TBL] [Abstract][Full Text] [Related]
30. Surgical and minimally invasive treatments for Peyronie's disease.
Kumar R; Nehra A
Curr Opin Urol; 2009 Nov; 19(6):589-94. PubMed ID: 19741538
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Management of Peyronie's Disease.
Trost LW; Gur S; Hellstrom WJ
Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
[TBL] [Abstract][Full Text] [Related]
32. Peyronie's disease: etiology, medical, and surgical therapy.
Hellstrom WJ; Bivalacqua TJ
J Androl; 2000; 21(3):347-54. PubMed ID: 10819440
[TBL] [Abstract][Full Text] [Related]
33. Medical management of Peyronie's disease.
Hellstrom WJ
J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
[TBL] [Abstract][Full Text] [Related]
34. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]